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 infection is propelling the development of an efficacious












The cellular immune responses to murine bone marrow-derived DCs










oral challenge was compared between HP-DC or PBS-DC immunized mice. The
effect of regulatory T-cell (Treg) depletion by anti-CD25 antibody on HP-DC




HP-DC induced a Th1-dominant response in vitro. In vivo, HP-DC
immunized mice were characterized by a mixed Th1/Th2 peripheral immune





 compared to PBS-DC immunized mice; no difference was found





 challenge was observed in HP-DC immunized mice compared to




-specific Th1 response and protective immunity were further enhanced













T-cell responses capable of limiting bacterial colonization. Our data support the
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 causes chronic gastritis in most infected
individuals and it is associated with gastroduodenal ulcers





by a combination of antibiotics and proton-pump inhibitors,





remains a significant threat to the half of the world’s
population infected with this pathogen. An improved





host immune response will contribute to the development





Studies in mice have revealed that interleukin (IL)-12,
a type 1 helper T cell (Th1)-promoting cytokine, plays a
critical role in vaccine-induced protective immunity [4,5].
























DCs leads to the induction of in vivo antigen-specific pro-
tective immunity against tumors [7], we speculate that an









have been assessed with some degree of success
[8,9], the advantage of DC vaccine is the priming of potent
adaptive immunity which, in tumor models, were shown
to be more efficacious than non-DC-based vaccines [10].
The goal of the current study was to examine the efficacy




 infection in vivo.
Our results showed that HP-DC stimulate the in vitro
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-specific Th responses, including Th1 and Th2, and
a lower bacterial colonization was observed in HP-DC mice
compared to DCs pulsed with phosphate-buffered saline
(PBS-DC). Depletion of Tregs with anti-CD25 antibodies in











vaccine should include both augmentation of Th1 effector






Specific pathogen-free female C57BL/6 mice aged 8–
10 weeks were purchased from Jackson Laboratory (Bar
Harbor, ME, USA) and housed in the Animal Maintenance
Facility at the University of Michigan Health System.
Experiments were conducted on mice aged 10–14 weeks.
All animal experiments were approved by the University
of Michigan Animal Care and Use Committee.
 
Media, Cytokines, and Neutralizing Antibodies
 
Complete medium (CM) consisted of RPMI-1640 with
10% heat-inactivated fetal calf serum, 2 mmol/L glutamine,
100 U/mL penicillin, and 100 µg/mL streptomycin. Two
recombinant cytokines (R&D Systems, Minneapolis, MN,
USA) were diluted in CM: mouse granulocyte/macrophage
colony-stimulating factor (GM-CSF, 10 ng/mL) and mouse
IL-4 (10 ng/mL). The antibodies used to deplete CD25+
cells were purified using protein G columns (Amersham
Biosciences, Piscataway, NJ, USA) from the supernatant of
the PC61 hybridoma cell line (American Type Culture
Collection, Manassas, VA, USA).
 









selective agar (BD Diagnostics, Bedford, MA, USA)
supplemented with 5% sterile horse blood, trimethoprim
(5 µg/mL), vancomycin (10 µg/mL), and nystatin (10 µg/mL)




C in a humidified microaerophilic
chamber (BBL Gas System, with CampyPak Plus packs, BD
Microbiology, Sparks, MD, USA).
 
Generation of Bone Marrow-Derived DCs
 
Erythrocyte-depleted murine bone marrow cells were









 cells/mL [12]. On day 6, nonadherent bone
marrow-derived DCs were harvested by vigorous pipetting
and enriched by gradient centrifugation using the
Optiprep density solution (Sigma, St. Louis, MO, USA).
The low-density interface containing the DCs was collected
by gentle aspiration. The recovered bone marrow-derived
DCs were washed twice with RPMI-1640 and cultured in
CM with GM-CSF (10 ng/mL).
 
Induction of Proliferative T-cell Responses In Vitro
 












CFU/mL) followed by washing to remove bacteria,

















 cells/mL) for 48 hours. Tritiated
deoxythymidine (Amersham Biosciences) was added to




Ci/well), and the plates were
incubated for 24 hours [7]. The plates were harvested at
completion and the radioactivity was measured using a
scintillation counter. Responses were reported as the mean
count per minute ± standard error of the mean (SEM)




Naïve C57BL/6 mice (n = 15 per group) were given an

















 cells per injection) on day 0 and
day 14. Phosphate-buffered saline-treated unstimulated










forming units (CFU) per milliliter of live organisms was
given to each mouse, three times over 1 week. Mice were
sacrificed 120 days after the first infection on day 0, and
spleens and stomachs were removed for analyses. The
stomachs were cut along the greater curvature into 2-mm
strips that included fundic and antral tissue. Paraffin
sections were prepared for hematoxylin and eosin (H&E).
The spleens were flushed with RPMI-1640 and CD4+ T
cells were isolated using Magnetic-Activated Cell Sorting
(MACS) microbeads (Miltenyi Biotech, Auburn, CA,
USA). Histologic scores were determined as mean ± SEM
according to the Eaton scoring method [13]. The
pathologist was blinded to the experimental manipulation













 sonicate by injection into the right
hind footpad 1 day before sacrifice. The left hind footpad
was given an equal volume of sterile saline. Footpad
thickness was measured with a dial thickness gauge
24 hours later, immediately before sacrifice, and the
difference in thickness between the control and the
























Mouse Th1/Th2 Cytokine Cytometric Bead Array Kit (BD
Biosciences PharMingen, San Diego, CA, USA) was used
according to the manufacturer’s instructions. Briefly, cell
culture supernatants and standards were incubated with
capture beads and PE Detection Reagent and analyzed with
the BD FACSCalibur™ system (BD Biosciences, San Jose,
CA, USA) using software supplied by the manufacturer.
 
Preparation of Conditioned Medium and Whole Cell 
Sonicate
 













 was grown in brain–heart infusion





. The culture supernatants were designated as
conditioned media. The pellets were sonicated on ice
as previously described [14] and then spun down for




. The supernatants were stored and






 Colonization and 
Gastric Tissue mRNA for IFN-γ
 
 and IL-5 by Real-Time 
Polymerase Chain Reaction 
 
A standard curve was generated by extracting total RNA,














 total bacteria. Total RNA also was isolated
from stomach tissue using TRIzol Reagent. Primer pairs
C97 and C98 [15] were used to amplify the 16S rRNA





amplicon of about 400 base pairs [16]. Additional primer






GAATCAG) and IL-5 (sense: GCAATGGAAGGCTGAGGCTG,
antisense: GGGTATGTGATCCTCCTGCGT C). Polymerase
chain reaction (PCR) amplifications were performed in























L Sybr Green (Molecular Probes, Carlsbad, CA, USA).
Each PCR amplification was performed in duplicate wells
in a Bio-Rad I-Cycler (I-Cycler IQ Real-Time PCR Detection





C for 10 minutes, followed by 35 two-temperature








C for 1 minute.
 
Fluorescence-Activated Cell Sorting (FACS)
 
DCs were washed twice with ice-cold PBS containing
0.5% bovine serum albumin and sodium azide. After a









Biosciences PharMingen), the cells were incubated with
either FITC and/or PE-conjugated antibodies or with
isotype control antibodies (1 : 100 dilution). The cells were
washed, resuspended in ice-cold 2% paraformaldehyde,
and analyzed using a Coulter XL Flow Cytometer
(Beckman Coulter, Miami, FL, USA). For intracellular
cytokine staining, cells were permeabilized with Perm/Fix
Solution (BD Biosciences PharMingen) before staining.
Both dot plots and histograms were obtained using
WinMDI version 2.8. The percentage of CD4+CD25+ Treg
determination was measured using Mouse Regulatory T




-Specific In Vitro Stimulation
 









mL) were isolated using MACS (Miltenyi Biotech) and
then stimulated for 7 days with syngeneic bone marrow-

















 sonicate alone served as controls.
 
Enzyme-Linked Immunosorbent Spot (ELISpot)
 




-specific CD4+ T cells were









 secretion) or for 48 hours (to measure IL-5
secretion). ELISpot (BD Biosciences Pharmingen) assays
were performed.
 
In Vivo Depletion of Regulatory T Cells (Tregs)
 
C57BL/6 mice (n = 9 or 10 per group) were treated IP with
either PBS or a single 1-mg dose of anti-CD25 mAb
(PC61). The success of Treg depletion was determined after









-test using commercially available software











-Pulsed DCs Stimulated Th1 Response 
In Vitro
 
The activation of antigen-presenting cells by bacterial
antigens can be measured by the surface expression of
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costimulatory molecules (e.g. CD80 and CD86) and by the
level of intracellular cytokine expression. To determine
whether H. pylori SS1 activates DCs, bone marrow-derived
DCs were cocultured with live H. pylori SS1 or PBS for
18 hours and cell surface expressions of CD40, CD80, and
CD86 and intracellular cytokine expression were
determined by FACS analysis. As shown in Fig. 1A,
H. pylori stimulated a significant upregulation of IL-12,
which suggests that bone marrow-derived DCs recognize
H. pylori in vitro and may prime a Th1 response. To
determine the type of Th response induced by HP-DC, we
measured the ability of bone marrow-derived DCs to
stimulate T-cell proliferation of splenocytes and the Th1/
Th2 cytokine profiles of the proliferating cells. HP-DC
induced significantly higher levels of cellular proliferation
than PBS-DC in a dose-dependent fashion (Fig. 1B,C). The
cytokine profiles of the proliferating cells as determined by
cytometric bead assay showed a Th1-dominant response
with increased levels of tumor necrosis factor (TNF)-α and
interferon (IFN)-γ and no measurable levels of IL-4 or IL-5
(Fig. 1D). These data suggest that HP-DC induce a Th1-
dominant response in vitro, a finding that is consistent
with reports using human monocyte-derived DCs [17,18].
HP-DC Induced a Delayed-Type Hypersensitivity 
Reaction Against H. pylori Sonicate In Vivo
Research suggests that the induction of an H. pylori-specific
Th1 response is a crucial component of protective
immunity against H. pylori [4,5]. Since HP-DC prime a Th1
response in vitro, we examined this response in vivo.
Using a general protocol for inducing protective antitumor
immunity, mice were injected IP with HP-DC or PBS- PBS-
DC. A booster injection was given 2 weeks later. The mice
were then challenged with live H. pylori to assess the
induction of anti-H. pylori immunity. After footpad
injection with H. pylori SS1 sonicate to measure H. pylori-
specific delayed-type hypersensitivity reaction, a significant
increase in footpad thickness was measured in the HP-DC
injected mice compared to the PBS-DC injected mice
(Fig. 2). These data indicate that HP-DC induce H. pylori-
specific cellular immune responses.
Induction of H. pylori-Specific Th1 and Th2 
Responses In Vivo
To determine the ability of HP-DC to induce H. pylori-
specific adaptive immune responses, CD4+ T cells isolated
from splenocytes of PBS-DC and HP-DC mice were
stimulated ex vivo with H. pylori sonicate. Naïve BM-DCs
were included as stimulators. ELISpot assays showed
significantly higher numbers of H. pylori-specific Th1 (i.e.
IFN-γ-producing CD4+) and Th2 (i.e. IL-5-producing
CD4+) cells in HP-DC mice (Fig. 3A,B). Thus, HP-DC are
capable of inducing Th1 and Th2 responses in vivo.
Induction of a Th1-dominant Gastric Response in 
HP-DC Mice
To characterize further the effective of HP-DC on host
response to H. pylori infection, total gastric RNA of mice
was assessed for IFN-γ and IL-5 expressions in order to
better define the Th1/Th2 responses at the gastric tissue
level. We found increased gastric IFN-γ mRNA in HP-DC
mice compared to PBS-DC mice and no measurable
difference for the IL-5 mRNA expression (Fig. 4A). Despite
detecting a mixed Th1/Th2 response in the peripheral
(spleen) immune compartment, HP-DC induced a Th1-
dominant response in the gastric tissue. This finding
indicates HP-DC primes a Th1-dominant response in the
gastric tissue despite a mixed Th1/Th2 in the periphery.
Therefore, it is critical to evaluate the gastric Th response
separately from peripheral Th response when determining
in vivo H. pylori-specific immunity.
A Reduced H. pylori Colonization was Observed 
in HP-DC Mice Compared to PBS-DC Mice
To determine whether the H. pylori-specific Th1-dominant
response induced by HP-DC could limit H. pylori
colonization, we performed quantitative reverse transcriptase
(RT)-PCR, which is a sensitive method of determining the
number of bacterial CFU in the stomach. There was a trend
toward lower bacterial colonization in HP-DC mice
compared to PBS-DC mice (p = .1) (Fig. 4B). To evaluate
whether this trend was due to more severe gastritis in
HP-DC mice, the degree of gastritis also was assessed using
the Eaton gastritis score for H. pylori-induced gastritis [14].
Quantification of H. pylori by the culture method showed
a similar trend (data not shown). No significant differences
in gastritis or polymorphonuclear neutrophil infiltration
scores were measured (Fig. 4C,D). Thus, HP-DC induced
a H. pylori-specific Th response and reduced H. pylori
colonization.
Depletion of Tregs by CD25 Antibody Further 
Enhanced the Ability of HP-DC Mice to Prime 
H. pylori-Specific Immunity
H. pylori-infected individuals have been shown to express
higher levels of Foxp3, a regulatory T-cell (Treg) marker.
We speculate that a depletion of Tregs by the anti-CD25
antibody PC61 may further enhance the ability of HP-DC
to limit H. pylori colonization. To examine this, PC61-
treated or nontreated mice vaccinated with HP-DC were
challenged with H. pylori and then analyzed 7 days
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Figure 1 H. pylori-pulsed dendritic cells (HP-DC) induce Th1 helper response in vitro. (A) H. pylori induces increased expression of DC costimulatory
molecules and intracellular cytokines. DCs were cocultured with PBS or H. pylori SS1 (MOI 1 : 100) for 18 hours. The expressions of surface costimulatory
molecules CD40, CD80, and CD86 and intracellular cytokines interleukin (IL)-4, IL-10, IL-12, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ were
assessed by fluorescence-activated cell sorting (FACS). Representative histograms from at least three independent experiments are shown (isotype
control: shaded area, phosphate-buffered saline (PBS) control: dotted line, and H. pylori-pulsed DCs: solid line) (B, C). HP-DC stimulate splenocyte
proliferation. Irradiated (5000 rads) HP-DC were cocultured with naïve syngeneic splenocytes for 72 hours. Micrographs show intense splenocyte
clustering in the HP-DC culture (×100). Splenocyte proliferation was quantified in a dose–response manner using a tritiated thymidine (3H) incorporation
assay. (D) HP-DC stimulate a Th1 response. The production of Th1/Th2 cytokines was measured using cytometric bead assays. HP-DC induced a type 1
helper T cell (Th1)-dominant response with increased levels of TNF-α and IFN-γ. Data shown represent results from three independent experiments.
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postinfection. We found that PC61-treated mice had a
lower percentage of splenic CD4+CD25+ T cells (Fig. 5A,B)
and an increased H. pylori-specific Th1 response (Fig. 5C)
with a significant reduction of H. pylori colonization in the
stomach (p = .0028) compared to non-PC61-treated HP-
DC immunized mice (Fig. 5D). No significant gastritis was
noted at this early time point in either group (data no
shown). These data indicate further enhancement of
H. pylori-specific Th1 response by removal of Tregs.
Discussion
Research has shown that human DCs pulsed with H. pylori
stimulate a Th1-dominant response [17,18]. Although
the use of DC vaccine as a routine immunization strategy
for H. pylori infection may appear impractical and too
technically complex, the role of DC-based vaccine may
benefit patients infected with antibiotic-resistant H. pylori,
especially those with mucosa-associated lymphoid tissue
(MALT) lymphoma in which eradication of H. pylori may
lead to disease regression [19]. We explored the possibility
of inducing bacteria-specific immunity with a DC-based
vaccine in a mouse model of H. pylori infection. Similar to
human DCs, mouse bone marrow-derived DCs pulsed
with live H. pylori stimulated a Th1-dominant response.
HP-DC mice challenged with H. pylori exhibit an H. pylori-
specific delayed-type hypersensitivity reaction, whereas
PBS-DC mice challenged with H. pylori do not. Analysis of
HP-DC-stimulated helper T-cell responses showed that
HP-DC induce a mixed peripheral Th1/Th2 response but a
Th1-dominant gastric response that lowered H. pylori
colonization. We also showed that enhancing the H. pylori-
specific Th1 response by Treg depletion further augmented
H. pylori immunity.
Figure 2 H. pylori-pulsed dendritic cells (HP-
DC) induce a delayed-type hypersensitivity
reaction to H. pylori sonicate. (A) Schematic
representation of experimental treatment of
mice (DCs pulsed with phosphate-buffered
saline (PBS-DC) mice vs. HP-DC mice). C57BL6
mice were injected with PBS-DC or HP-DC on
day 0 and day 14. Oral challenge with H. pylori
SS1 (108 live organisms) was administered
three times in 1 week beginning on day 21.
Mice were sacrificed on day 120. (B) HP-DC
vaccination resulted in an H. pylori-specific
delayed-type hypersensitivity reaction. The
right hind footpads of the mice from each
group were injected with 10 μg in 30 μL of
H. pylori SS1 sonicate and the left hind
footpads with 30 μL of PBS. Footpad thickness
was measured 24 hours later and expressed as
change of thickness from PBS control. Results
are from three independent experiments.
Figure 3 Induction of in vivo H. pylori-specific
Th1 and Th2 responses by H. pylori-pulsed
dendritic cells (HP-DC). CD4+ T cells were
isolated using MACS microbeads from DCs
pulsed with phosphate-buffered saline (PBS-
DC) (n = 15) or HP-DC (n = 16) mice. CD4+ T
cells were stimulated in vitro for 7 days with
H. pylori SS1 sonicate and naïve bone marrow-
derived DCs. H. pylori-specific interferon
(IFN)-γ-producing (Th1) and interleukin (IL)-5-
producing (Th2) CD4+ T cells were quantified
using ELISpot (A, B). Data are from three
independent experiments.
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Otsu et al. reported that the transfer of H. pylori-pulsed
immortalized murine DC cell line (JAWS II) effectively
induced therapeutic immunity against H. pylori infection
(reported as a 2-log reduction in bacterial colonization)
[20]. In our study, HP-DC induced a 1.25-log reduction in
bacterial colonization compared to PBS-DC. The difference
in these results may be explained by their use of immor-
talized DC cell lines versus bone marrow-derived primary
DCs used in this study. Immortalized cells may have higher
efficacy in vivo due to prolonged antigen priming. Another
difference between the two studies is the methods used to
quantify H. pylori colonization (i.e. culture by Otsu et al.
vs. real-time PCR in this study). In our laboratory, we
find that real-time PCR quantification of H. pylori
colonization is more sensitive than culturing methods
(data not shown).
The current study shed light on the complexity of
vaccine development against H. pylori. As the debate over
the requirement of a Th1 response for vaccine-induced
protective immunity continues [4,5], our finding supports
the current paradigm that an effective Th1 response
protects against H. pylori infection. Ineffective Th1 effector
response, suggested by our previous study of a defective
Th1 priming by dendritic cells [6], may result in the
persistent colonization and the development of chronic
gastritis. Using a potent inducer of antigen-specific cellular
immunity with DC vaccine, we show that H. pylori-specific
Th1 response can be induced in vivo. A Th2 response
also was augmented by DC vaccine but its role is less
well-defined as protective immunity could be achieved in
B-cell-deficient mice [21,22]. Additional support for the
importance of effector Th1 response was reported by Rad
Figure 4 Induction of a Th1-dominant gastric
immune response that limited H. pylori
colonization. Total stomach RNA was isolated
from DCs pulsed with phosphate-buffered
saline (PBS-DC) or H. pylori-pulsed dendritic
cells (HP-DC) mice. Quantitative reverse
transcriptase PCR was performed to measure
mRNA expressions of interferon-γ and
interleukin-5 (A), and to quantify H. pylori
colonization (B). HP-DC vaccine reduced
H. pylori colonization. (C, D) Histologic and
polymorphic neutrophil scores of stomach
tissue from HP-DC were similar to the scores
from PBS-DC mice. Results are from three
independent experiments.
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et al., where depletion of CD4+CD25+ Tregs correlated
with a reduction in H. pylori colonization [23]. In our
study, a depletion of CD4+CD25+ Tregs further enhances
DC vaccine primed H. pylori-specific Th1 response and
reduced bacterial colonization. As an intact Th1 response
is essential for vaccine-induced protection against H. pylori,
a balanced, nonrestrictive Treg response may be the other
determinant of whether H. pylori sterilization can be
achieved. Understanding the interaction between H. pylori
and host immune system with respect to induction of Th
and Treg response will be critical for the success of a vacci-
nation strategy. Furthermore, since Treg is also involved in
regulation of gastric inflammation [23], manipulations to
upregulate this response may prove to be beneficial in sup-
pressing chronic gastritis.
In summary, our study shows that DC-based vaccine is
capable of inducing protective H. pylori-specific immunity.
Treg depletion with anti-CD25 antibodies enhanced the
ability of DC vaccine to prime a H. pylori-specific immu-
nity. Our study supports the critical role of a Th1-skewed
response in anti-H. pylori immunity. These studies may
shed light on novel strategies to modulate the host
response to eradicate H. pylori infection.
The preliminary results of this study were presented orally at the
2004 Digestive Disease Week and published in abstract form in
Gastroenterology (Vol. 126(4) Suppl. 2: A790). This study was sup-
ported by grants from the National Institutes of Health (1 KO8
DK0669907-01 and P30 DK034933), the Foundation of Digestive
Health and Nutrition (Fellow-to-Faculty Transition Award), and
the GlaxoSmithKline Institute of Digestive Health (Basic Research
Award).
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